A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
Saye H Khoo, Richard FitzGerald, Geoffrey Saunders, Calley Middleton, Shazaad Ahmed, Christopher J Edwards, Dennis Hadjiyiannakis, Lauren Walker, Rebecca Lyon, Victoria Shaw, Pavel Mozgunov, Jimstan Periselneris, Christie Woods, Katie Bullock, Colin Hale, Helen Reynolds, Nichola Downs, Sean Ewings, Amanda Buadi, David Cameron, Thomas Edwards, Emma Knox, I’ah Donovan-Banfield, William Greenhalf, Justin Chiong, Lara Lavelle-Langham, Michael Jacobs, Wendy Painter, Wayne Holman, David G Lalloo, Michelle Tetlow, Julian A Hiscox, Thomas Jaki, Thomas Fletcher, Gareth Griffiths the AGILE CST-2 Study Group
doi: https://doi.org/10.1101/2022.07.20.22277797
Saye H Khoo
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
2Tropical and Infectious Disease Unit, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
FRCPRichard FitzGerald
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
3NIHR Royal Liverpool and Broadgreen Clinical Research, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
PhDGeoffrey Saunders
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
MScCalley Middleton
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
Shazaad Ahmed
5NIHR Manchester Clinical Research Facility, Manchester, University NHS Foundation Trust, Manchester, UK
FRCPathChristopher J Edwards
6NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK
7Human Development and Health School, University of Southampton, Southampton, UK
MDDennis Hadjiyiannakis
8NIHR Lancashire Clinical Research Facility, Lancashire Teaching Hospitals NHS Foundation Trust
FRCPLauren Walker
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
3NIHR Royal Liverpool and Broadgreen Clinical Research, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
PhDRebecca Lyon
3NIHR Royal Liverpool and Broadgreen Clinical Research, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
PGCertVictoria Shaw
9Clinical Directorate, University of Liverpool, Liverpool, UK
PhDPavel Mozgunov
10MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
PhDJimstan Periselneris
11NIHR Kings Clinical Research Facility, King’s College Hospital NHS Foundation Trust, London, UK
PhDChristie Woods
3NIHR Royal Liverpool and Broadgreen Clinical Research, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
PGDipKatie Bullock
12Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
MScColin Hale
3NIHR Royal Liverpool and Broadgreen Clinical Research, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
BScHelen Reynolds
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
MPhilNichola Downs
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
PGCertSean Ewings
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
PhDAmanda Buadi
6NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK
MScDavid Cameron
8NIHR Lancashire Clinical Research Facility, Lancashire Teaching Hospitals NHS Foundation Trust
BMBSThomas Edwards
13Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine, Liverpool, UK
PhDEmma Knox
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
PhDI’ah Donovan-Banfield
14Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
MResWilliam Greenhalf
12Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
PhDJustin Chiong
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
MBALara Lavelle-Langham
12Molecular & Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
BScMichael Jacobs
16Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK
FRCPWendy Painter
17Ridgeback Biotherapeutics, Miami, Florida, USA
MDWayne Holman
17Ridgeback Biotherapeutics, Miami, Florida, USA
MDDavid G Lalloo
18Director, Liverpool School of Tropical Medicine, Liverpool, UK
FRCPMichelle Tetlow
1Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
MScJulian A Hiscox
14Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
PhDThomas Jaki
10MRC Biostatistics Unit, University of Cambridge, Cambridge, UK
19Computational Statistics, University of Regensburg, Regensburg, Germany
PhDThomas Fletcher
2Tropical and Infectious Disease Unit, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK
20Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK
PhDGareth Griffiths
4Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
PhD
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 24, 2022.
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
Saye H Khoo, Richard FitzGerald, Geoffrey Saunders, Calley Middleton, Shazaad Ahmed, Christopher J Edwards, Dennis Hadjiyiannakis, Lauren Walker, Rebecca Lyon, Victoria Shaw, Pavel Mozgunov, Jimstan Periselneris, Christie Woods, Katie Bullock, Colin Hale, Helen Reynolds, Nichola Downs, Sean Ewings, Amanda Buadi, David Cameron, Thomas Edwards, Emma Knox, I’ah Donovan-Banfield, William Greenhalf, Justin Chiong, Lara Lavelle-Langham, Michael Jacobs, Wendy Painter, Wayne Holman, David G Lalloo, Michelle Tetlow, Julian A Hiscox, Thomas Jaki, Thomas Fletcher, Gareth Griffiths
medRxiv 2022.07.20.22277797; doi: https://doi.org/10.1101/2022.07.20.22277797
A Randomised -Controlled Phase 2 trial of Molnupiravir in Unvaccinated and Vaccinated Individuals with Early SARS-CoV-2
Saye H Khoo, Richard FitzGerald, Geoffrey Saunders, Calley Middleton, Shazaad Ahmed, Christopher J Edwards, Dennis Hadjiyiannakis, Lauren Walker, Rebecca Lyon, Victoria Shaw, Pavel Mozgunov, Jimstan Periselneris, Christie Woods, Katie Bullock, Colin Hale, Helen Reynolds, Nichola Downs, Sean Ewings, Amanda Buadi, David Cameron, Thomas Edwards, Emma Knox, I’ah Donovan-Banfield, William Greenhalf, Justin Chiong, Lara Lavelle-Langham, Michael Jacobs, Wendy Painter, Wayne Holman, David G Lalloo, Michelle Tetlow, Julian A Hiscox, Thomas Jaki, Thomas Fletcher, Gareth Griffiths
medRxiv 2022.07.20.22277797; doi: https://doi.org/10.1101/2022.07.20.22277797
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12543)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4418)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2844)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6764)
- Radiology and Imaging (1487)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)